Handa Pharmaceuticals, Inc. (TPEX:6620)

Handa Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	995.52	597.38	667.05	365.91	263.31	280.12
Short-Term Investments	1,855	1,232	1,650	-	19.96	34.98
Cash & Short-Term Investments	2,850	1,829	2,317	365.91	283.27	315.09
Cash Growth	12.73%	-21.04%	533.18%	29.18%	-10.10%	-50.47%
Accounts Receivable	502.38	190.44	376.37	153.48	7.79	21.64
Other Receivables	9.66	29.29	6.74	8.02	7.62	6.08
Receivables	512.04	219.73	383.11	161.51	15.4	27.72
Inventory	-	41.24	-	-	-	-
Prepaid Expenses	15.09	12.16	11.63	2.42	2.33	22.38
Other Current Assets	-	2.66	3.27	63.02	13.34	43.7
Total Current Assets	3,377	2,105	2,715	592.86	314.33	408.9
Property, Plant & Equipment	87.41	75.78	21.03	43.04	41.83	44.78
Long-Term Investments	56.23	62.2	61.86	-	-	-
Goodwill	35.83	35.93	34.95	34.95	34.95	34.95
Other Intangible Assets	750.39	917.05	0.59	1.07	1.31	-
Long-Term Deferred Tax Assets	233.48	243.52	202.85	117.23	105.18	91.08
Other Long-Term Assets	133.47	1.72	1.04	1.43	0.93	2.73
Total Assets	4,674	3,441	3,037	790.56	498.53	582.44
Accounts Payable	17.47	20.78	13.97	6.22	1.08	9.36
Accrued Expenses	-	35.42	51.38	18.53	14.61	17.59
Current Portion of Leases	9.88	7.27	5.57	10.14	6.2	7.82
Current Income Taxes Payable	63.24	-	124.76	1.34	0.01	0.01
Other Current Liabilities	277.56	177.89	13.81	9.13	7.84	3.12
Total Current Liabilities	368.15	241.36	209.49	45.35	29.73	37.9
Long-Term Leases	40.73	32.83	7.67	19.46	5.7	5.54
Long-Term Unearned Revenue	-	39.43	-	-	-	-
Long-Term Deferred Tax Liabilities	2.79	7.28	23.81	4.63	-	-
Other Long-Term Liabilities	38.09	3.19	39.92	-	-	-
Total Liabilities	449.76	324.09	280.88	69.44	35.43	43.44
Common Stock	1,583	1,412	1,411	1,302	1,221	1,157
Additional Paid-In Capital	2,244	1,254	1,253	579.02	338.41	231.74
Retained Earnings	677.99	546.87	215.2	-1,089	-1,049	-801
Treasury Stock	-114.4	-56.52	-	-	-	-
Comprehensive Income & Other	-166.42	-39.45	-123.18	-70.76	-47.93	-48.76
Shareholders' Equity	4,224	3,117	2,756	721.12	463.1	539
Total Liabilities & Equity	4,674	3,441	3,037	790.56	498.53	582.44
Total Debt	50.61	40.1	13.24	29.59	11.89	13.36
Net Cash (Debt)	2,800	1,789	2,304	336.32	271.38	301.73
Net Cash Growth	12.37%	-22.33%	584.95%	23.93%	-10.06%	-51.01%
Net Cash Per Share	19.09	12.68	17.10	2.68	2.31	2.61
Filing Date Shares Outstanding	151.83	140.48	141.09	130.16	122.13	115.7
Total Common Shares Outstanding	151.83	140.48	141.09	130.16	122.13	115.7
Working Capital	3,009	1,864	2,505	547.5	284.61	371
Book Value Per Share	27.82	22.19	19.54	5.54	3.79	4.66
Tangible Book Value	3,438	2,164	2,721	685.11	426.85	504.05
Tangible Book Value Per Share	22.65	15.41	19.28	5.26	3.50	4.36
Machinery	-	60.95	55.98	66.98	76.07	70.51
Leasehold Improvements	-	15.3	12.64	15.54	15.49	15.79

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.